Olfen Patch (Diclofenac Sodium)

Diclofenac sodium inhibits the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which are responsible for producing prostaglandins that cause inflammation, pain and fever. By blocking prostaglandin synthesis at the site of application, the patch reduces local inflammatory responses while limiting systemic exposure.

The prescribed dose of Olfen Patch is determined by a qualified healthcare professional based on the patient’s condition, severity of symptoms and treatment goals. The prescriber will select the appropriate patch size, strength and duration of use, and will provide specific instructions for application and replacement.

Diclofenac sodium should be used during pregnancy or lactation only if clearly needed and after a risk‑benefit assessment by a healthcare provider. Systemic exposure from a topical patch is lower than oral NSAIDs, but caution is still advised, especially in the third trimester and while nursing.

To order Olfen Patch, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team will provide pricing, availability, shipping details and any necessary import documentation.

Olfen Patch delivers diclofenac directly to the skin, providing targeted pain relief with lower systemic absorption compared with oral tablets. This can reduce the risk of gastrointestinal side effects and systemic toxicity, making the patch a useful alternative for patients who need localized therapy or who cannot tolerate oral NSAIDs.

Olfen Patch should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the patches away from extreme heat or freezing conditions, and discard any patch that appears damaged or discolored before use.

The patch is applied to clean, dry, intact skin on the area of pain. Press firmly for several seconds to ensure good contact, and leave it in place for the duration prescribed, usually up to 12‑24 hours. After removal, the skin should be inspected for irritation before applying a new patch.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, systemic hypersensitivity reactions like anaphylaxis, and cardiovascular events such as heart attack or stroke. Patients should seek immediate medical attention if they experience widespread rash, swelling, difficulty breathing, or chest pain.

Olfen Patch should not be used by individuals with a known allergy to diclofenac, other NSAIDs, or any component of the patch. It is also contraindicated in patients with active gastrointestinal ulceration, severe heart failure, or uncontrolled hypertension, and should be avoided in the third trimester of pregnancy unless specifically advised by a physician.